Brief: Humacyte Submits Marketing Authorization Application For Symvess® In Israel For Vascular Trauma Repair
17/03/2026 12:05
March 17 (Reuters) - Humacyte Inc HUMA.O: HUMACYTE SUBMITS MARKETING AUTHORIZATION APPLICATION FOR SYMVESS® IN ISRAEL FOR VASCULAR TRAUMA REPAIR Source text: ID:nGNX5QMtfJ Further company coverage: HUMA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary